Therapeutic Asset Ratings
128 results matching 1 filter
133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Gevokizumab
Colon Cancer
NSABP Foundation Inc
P2
CCC
(48)
ibi310
Colon Cancer
Peking University
P2
CCC
(48)
Idarubicine
Colon Cancer
City of Hope Medical Center
P2
CCC
(48)
IMMUNOGLOBULIN HALF-IG G1-KAPPA/SCFV-H-CH2-CH3, ANTI-(HOMO SAPIENS CTLA4 (CYTOTOXIC T-LYMPHOCYTE-ASSOCIATED PROTEIN 4, CD152)) AND ANTI-(HOMO SAPIENSPDCD1 (PROGRAMMED CELL DEATH 1, PD-1, PD1, CD279)), MONOCLONAL ANTIBODY, BISPECIFIC
Colon Cancer
M.D. Anderson Cancer Center
P2
CCC
(48)
Indocyanine Green
Colon Cancer
Tanta University
P2
CCC
(48)
IRON(II) SULPHATE (1:1), HEPTAHYDRATE
Colon Cancer
Korea University Guro Hospital
P2
CCC
(48)
Iron Isomaltoside
Colon Cancer
Korea University Guro Hospital
P2
CCC
(48)
Ivonescimab
Colon Cancer
Sun Yat-sen University
P2
CCC
(48)
LENVATINIB
Colon Cancer
Peking University
P2
CCC
(48)
lt-002 (lactobacillus reuteri atg-f4
Colon Cancer
Chungnam National University Hospital
P2
CCC
(48)
Mesalamine
Colon Cancer
Ann-Sofie Backman
P2
CCC
(48)
Pyrotinib
Colon Cancer
The First Affiliated Hospital of Zhengzhou University
P2
CCC
(48)
Raltitrexed
Colon Cancer
Fudan University
P2
CCC
(48)
rc48-adc
Colon Cancer
The First Affiliated Hospital of Zhengzhou University
P2
CCC
(48)
Rimegepant
Colon Cancer
Fudan University
P2
CCC
(48)
Serplulimab
Colon Cancer
Ruijin Hospital
P2
CCC
(48)
Tegafur Gimeracil Oteracil Potassium
Colon Cancer
Guangzhou University of Traditional Chinese Medicine
P2
CCC
(48)
Terelizumab
Colon Cancer
fan li
P2
CCC
(48)
Tuvonralimab
Colon Cancer
Fujian Medical University
P2
CCC
(48)
Vebreltinib
Colon Cancer
Apollomics Inc.
P2
CCC
(48)
Abemaciclib
Colon Cancer
M.D. Anderson Cancer Center
P1/2
CC
(46)
Cea-Targeted Car-T
Colon Cancer
Chongqing Precision Biotech Co., Ltd
P1/2
CC
(46)
Pegylated Interferon-Alpha-2A
Colon Cancer
Zealand University Hospital
P2
CC
(45)
e-602
Colon Cancer
Palleon Pharmaceuticals, Inc.
P1/2
CC
(44)
TIL
Colon Cancer
Essen Biotech
P1/2
CC
(44)
Showing 51 to 75 of 128 assets
Previous
Page 3 of 6
Next